Caseware UK (AP4) 2023.0.135 2023.0.135 2024-03-312024-03-31General and specialist medical practice activities102023-04-01false124falsetrueThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.false 12573258 2023-04-01 2024-03-31 12573258 2022-04-01 2023-03-31 12573258 2024-03-31 12573258 2023-03-31 12573258 c:Director3 2023-04-01 2024-03-31 12573258 d:Buildings d:LongLeaseholdAssets 2023-04-01 2024-03-31 12573258 d:Buildings d:LongLeaseholdAssets 2024-03-31 12573258 d:Buildings d:LongLeaseholdAssets 2023-03-31 12573258 d:OfficeEquipment 2023-04-01 2024-03-31 12573258 d:OfficeEquipment 2024-03-31 12573258 d:OfficeEquipment 2023-03-31 12573258 d:OfficeEquipment d:OwnedOrFreeholdAssets 2023-04-01 2024-03-31 12573258 d:OtherPropertyPlantEquipment 2023-04-01 2024-03-31 12573258 d:OtherPropertyPlantEquipment 2024-03-31 12573258 d:OtherPropertyPlantEquipment 2023-03-31 12573258 d:OtherPropertyPlantEquipment d:OwnedOrFreeholdAssets 2023-04-01 2024-03-31 12573258 d:OwnedOrFreeholdAssets 2023-04-01 2024-03-31 12573258 d:Goodwill 2023-04-01 2024-03-31 12573258 d:Goodwill 2024-03-31 12573258 d:Goodwill 2023-03-31 12573258 d:CurrentFinancialInstruments 2024-03-31 12573258 d:CurrentFinancialInstruments 2023-03-31 12573258 d:CurrentFinancialInstruments d:WithinOneYear 2024-03-31 12573258 d:CurrentFinancialInstruments d:WithinOneYear 2023-03-31 12573258 d:ShareCapital 2024-03-31 12573258 d:ShareCapital 2023-03-31 12573258 d:RetainedEarningsAccumulatedLosses 2024-03-31 12573258 d:RetainedEarningsAccumulatedLosses 2023-03-31 12573258 c:OrdinaryShareClass1 2023-04-01 2024-03-31 12573258 c:OrdinaryShareClass1 2024-03-31 12573258 c:OrdinaryShareClass1 2023-03-31 12573258 c:OrdinaryShareClass2 2023-04-01 2024-03-31 12573258 c:OrdinaryShareClass2 2024-03-31 12573258 c:OrdinaryShareClass2 2023-03-31 12573258 c:OrdinaryShareClass3 2023-04-01 2024-03-31 12573258 c:OrdinaryShareClass3 2024-03-31 12573258 c:OrdinaryShareClass3 2023-03-31 12573258 c:OrdinaryShareClass4 2023-04-01 2024-03-31 12573258 c:OrdinaryShareClass4 2024-03-31 12573258 c:OrdinaryShareClass4 2023-03-31 12573258 c:OrdinaryShareClass5 2023-04-01 2024-03-31 12573258 c:OrdinaryShareClass5 2024-03-31 12573258 c:OrdinaryShareClass5 2023-03-31 12573258 c:FRS102 2023-04-01 2024-03-31 12573258 c:IndependentExaminationCharity 2023-04-01 2024-03-31 12573258 c:FullAccounts 2023-04-01 2024-03-31 12573258 c:PrivateLimitedCompanyLtd 2023-04-01 2024-03-31 12573258 d:WithinOneYear 2024-03-31 12573258 d:WithinOneYear 2023-03-31 12573258 d:BetweenOneFiveYears 2024-03-31 12573258 d:BetweenOneFiveYears 2023-03-31 12573258 d:Goodwill d:ExternallyAcquiredIntangibleAssets 2023-04-01 2024-03-31 12573258 d:Goodwill d:OwnedIntangibleAssets 2023-04-01 2024-03-31 12573258 e:PoundSterling 2023-04-01 2024-03-31 xbrli:shares iso4217:GBP xbrli:pure

Registered number: 12573258










HEALTHCARE CENTRAL LONDON LIMITED










FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE YEAR ENDED 31 MARCH 2024

 
HEALTHCARE CENTRAL LONDON LIMITED
 
 
  
CHARTERED ACCOUNTANTS' REPORT TO THE BOARD OF DIRECTORS ON THE PREPARATION OF THE UNAUDITED STATUTORY FINANCIAL STATEMENTS OF HEALTHCARE CENTRAL LONDON LIMITED
FOR THE YEAR ENDED 31 MARCH 2024

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of Healthcare Central London Limited for the year ended 31 March 2024 which comprise  the Balance sheet, the Statement of changes in equity and the related notes from the Company's accounting records and from information and explanations you have given us.

As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW)we are subject to its ethical and other professional requirements which are detailed at https://www.icaew.com /regulation.

This report is made solely to the Board of Directors of Healthcare Central London Limited, as a body, in accordance with the terms of our engagement letter. Our work has been undertaken solely to prepare for your approval the financial statements of Healthcare Central London Limited and state those matters that we have agreed to state to the Board of Directors of Healthcare Central London Limited, as a body, in this report in accordance with ICAEW Technical Release TECH07/16AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Healthcare Central London Limited and its Board of Directors, as a body, for our work or for this report. 

It is your duty to ensure that Healthcare Central London Limited has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of Healthcare Central London Limited. You consider that Healthcare Central London Limited is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or review of the financial statements of Healthcare Central London Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.

  



MHA
Chartered Accountants
Victoria Court
17-21 Ashford Road
Maidstone
ME14 5DA
15 November 2024
Page 1

 
HEALTHCARE CENTRAL LONDON LIMITED
REGISTERED NUMBER: 12573258

BALANCE SHEET
AS AT 31 MARCH 2024

2024
2023
Note
£
£

Fixed assets
  

Intangible assets
 4 
90,000
-

Tangible assets
 5 
201,465
-

  
291,465
-

Current assets
  

Debtors: amounts falling due within one year
 6 
4,397,961
215,110

Cash at bank and in hand
  
1,530,292
4,390

  
5,928,253
219,500

Creditors: amounts falling due within one year
 7 
(5,847,141)
-

Net current assets
  
 
 
81,112
 
 
219,500

Total assets less current liabilities
  
372,577
219,500

  

Net assets
  
372,577
219,500


Capital and reserves
  

Called up share capital 
 8 
219,500
219,500

Profit and loss account
  
153,077
-

  
372,577
219,500


Page 2

 
HEALTHCARE CENTRAL LONDON LIMITED
REGISTERED NUMBER: 12573258
    
BALANCE SHEET (CONTINUED)
AS AT 31 MARCH 2024

The directors consider that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The Company's financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of income and retained earnings in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf by: 




R Chopra
Director

Date: 12 November 2024

The notes on pages 4 to 12 form part of these financial statements.

Page 3

 
HEALTHCARE CENTRAL LONDON LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024

1.


General information

Healthcare Central London Limited is a private company, limited by shares, incorporated in England and Wales in the United Kingdom. The registered office address is Capital House, 25 Chapel Street, London, United Kingdom, NW1 5DH.
These financial statements are presented in pound sterling, the functional currency of the Company, and rounded to the nearest £1.
The principal activity of the Company is the provision of general and specialist medical practice activities.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006.

The preparation of financial statements in compliance with FRS 102 requires the use of certain critical accounting estimates. It also requires management to exercise judgement in applying the Company's accounting policies.

The following principal accounting policies have been applied:

 
2.2

Revenue

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Rendering of services

Revenue from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied:
the amount of revenue can be measured reliably;
it is probable that the Company will receive the consideration due under the contract;
the stage of completion of the contract at the end of the reporting period can be measured reliably; and
the costs incurred and the costs to complete the contract can be measured reliably.

 
2.3

Leased assets: the Company as lessee

Assets obtained under hire purchase contracts and finance leases are capitalised as tangible fixed assets. Assets acquired by finance lease are depreciated over the shorter of the lease term and their useful lives. Assets acquired by hire purchase are depreciated over their useful lives. Finance leases are those where substantially all of the benefits and risks of ownership are assumed by the company. Obligations under such agreements are included in creditors net of the finance charge allocated to future periods. The finance element of the rental payment is charged to profit or loss so as to produce a constant periodic rate of charge on the net obligation outstanding in each period.

Page 4

 
HEALTHCARE CENTRAL LONDON LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024

2.Accounting policies (continued)

 
2.4

Pensions

Defined contribution pension plan

The Company operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the Company pays fixed contributions into a separate entity. Once the contributions have been paid the Company has no further payment obligations.

The contributions are recognised as an expense in profit or loss when they fall due. Amounts not paid are shown in accruals as a liability in the Balance sheet. The assets of the plan are held separately from the Company in independently administered funds.

NHS pension scheme

The company provides certain members of staff access to the NHS Pension Scheme. The scheme is an unfunded, defined benefit scheme that covers NHS employers, General Practices and other bodies, allowed under the direction of the Secretary of State, in England and Wales. The scheme is not designed to be run in a way that would enable employing bodies to identify their share of the underlying scheme assets and liabilities. Therefore, the scheme is accounted for as if it were a defined contribution scheme: the cost to the employer of participating in the scheme is taken as equal to the contributions payable to the scheme for the accounting period.

 
2.5

Taxation

Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the balance sheet date in the countries where the Company operates and generates income.

Page 5

 
HEALTHCARE CENTRAL LONDON LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024

2.Accounting policies (continued)

 
2.6

Intangible assets

Goodwill

Goodwill represents the difference between amounts paid on the cost of a business combination and the acquirer’s interest in the fair value of its identifiable assets and liabilities of the acquiree at the date of acquisition. Subsequent to initial recognition, goodwill is measured at cost less accumulated amortisation and accumulated impairment losses. Goodwill is amortised on a straight-line basis to the Statement of income and retained earnings over its useful economic life.

Other intangible assets

Intangible assets are initially recognised at cost. After recognition, under the cost model, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

All intangible assets are considered to have a finite useful life. If a reliable estimate of the useful life cannot be made, the useful life shall not exceed ten years.

 The estimated useful lives range as follows:

Goodwill
-
10
years

 
2.7

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, using the straight-line method.

Depreciation is provided on the following basis:

Leasehold improvements
-
5 years
Office equipment
-
5 years
Medical equipment
-
5 years

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

 
2.8

Debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

Page 6

 
HEALTHCARE CENTRAL LONDON LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024

2.Accounting policies (continued)

 
2.9

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
2.10

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

 
2.11

Financial instruments

The Company has elected to apply the provisions of Section 11 “Basic Financial Instruments” of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the Company's Balance sheet when the Company becomes party to the contractual provisions of the instrument.

Basic financial assets

Basic financial assets, which include trade and other receivables, cash and bank balances, are initially measured at their transaction price including transaction costs and are subsequently carried at their amortised cost using the effective interest method, less any provision for impairment, unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest.

Discounting is omitted where the effect of discounting is immaterial. The Company's cash and cash equivalents, trade and most other receivables due with the operating cycle fall into this category of financial instruments.

Financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instruments any contract that evidences a residual interest in the assets of the Company after the deduction of all its liabilities.

Basic financial liabilities, which include trade and other payables, bank loans and other loans are initially measured at their transaction price after transaction costs. When this constitutes a financing transaction, whereby the debt instrument is measured at the present value of the future receipts discounted at a market rate of interest. Discounting is omitted where the effect of discounting is immaterial.

Debt instruments are subsequently carried at their amortised cost using the effective interest rate method.
 
Page 7

 
HEALTHCARE CENTRAL LONDON LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024

2.Accounting policies (continued)


2.11
Financial instruments (continued)


Trade payables are obligations to pay for goods and services that have been acquired in the ordinary course of business from suppliers. Trade payables are classified as current liabilities if the payment is due within one year. If not, they represent non-current liabilities. Trade payables are initially recognised at their transaction price and subsequently are measured at amortised cost using the effective interest method. Discounting is omitted where the effect of discounting is immaterial.


3.


Employees

2024
2023
£
£

Wages and salaries
4,985,447
-

Social security costs
493,970
-

Cost of defined contribution pension scheme
397,195
-

5,876,612
-


The average monthly number of employees, including the directors, during the year was as follows:


        2024
        2023
            No.
            No.







Directors
10
10



Employees
114
-

124
10

Page 8

 
HEALTHCARE CENTRAL LONDON LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024

4.


Intangible assets




Goodwill

£



Cost


Additions
100,000



At 31 March 2024

100,000



Amortisation


Charge for the year on owned assets
10,000



At 31 March 2024

10,000



Net book value



At 31 March 2024
90,000



At 31 March 2023
-

On 1 April 2023, the business of Central Healthcare London CIC was transferred to the Company at a valuation of £100,000, giving rise to goodwill at the same value. Goodwill is amortised over 10 years, being the directors' best estimate of the useful expected life of transferred contracts.



Page 9

 
HEALTHCARE CENTRAL LONDON LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024

5.


Tangible fixed assets





Leasehold improvements
Office equipment
Medical equipment
Total

£
£
£
£



Cost or valuation


Additions
117,247
96,948
22,880
237,075



At 31 March 2024

117,247
96,948
22,880
237,075



Depreciation


Charge for the year on owned assets
25,361
8,131
2,118
35,610



At 31 March 2024

25,361
8,131
2,118
35,610



Net book value



At 31 March 2024
91,886
88,817
20,762
201,465



At 31 March 2023
-
-
-
-


6.


Debtors

2024
2023
£
£


Trade debtors
2,407,943
-

Other debtors
42,691
-

Called up share capital not paid
215,110
215,110

Prepayments and accrued income
1,732,217
-

4,397,961
215,110


Page 10

 
HEALTHCARE CENTRAL LONDON LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024

7.


Creditors: Amounts falling due within one year

2024
2023
£
£

Trade creditors
941,809
-

Amounts due to related undertakings
280,595
-

Bank accounts held on behalf of third parties
1,233,453
-

Corporation tax
60,671
-

Other taxation and social security
177,240
-

Other creditors
301,508
-

Accruals and deferred income
2,851,865
-

5,847,141
-



8.


Share capital

2024
2023
£
£
Allotted, called up and fully paid



6 (2023 - 6) Ordinary AV shares of £0.01 each
-
-
10 (2023 - 10) Ordinary BV shares of £0.01 each
-
-
6 (2023 - 6) Ordinary CV shares of £0.01 each
-
-
8 (2023 - 8) Ordinary DV shares of £0.01 each
-
-

-

-

Allotted, called up and partly paid



85 (2023 - 85) Ordinary Redeemable AC shares of £500.00 each
42,500
42,500
155 (2023 - 155) Ordinary Redeemable BC shares of £500.00 each
77,500
77,500
70 (2023 - 70) Ordinary Redeemable CC shares of £500.00 each
35,000
35,000
129 (2023 - 129) Ordinary Redeemable DC shares of £500.00 each
64,500
64,500

219,500

219,500



9.


Pension commitments

The Company operates a defined contributions pension scheme. The pension cost charge represents contributions payable by the Company to the fund and amounted to £397,195 (2023: £Nil). Contributions totalling £75,612 (2023: £Nil) were payable to the fund at the balance sheet date and are included in creditors.

Page 11

 
HEALTHCARE CENTRAL LONDON LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024

10.


Commitments under operating leases

At 31 March 2024 the Company had future minimum lease payments due under non-cancellable operating leases for each of the following periods:

2024
2023
£
£


Not later than 1 year
148,659
-

Later than 1 year and not later than 5 years
470,753
-

619,412
-


11.


Related party transactions

During the year, the Company received amounts from Central London Healthcare CIC, a company under common control for £205,718 (2023: £Nil) for management recharges, and £82,571 (2023: £Nil) for training cost recharges. The balance due to Central London Healthcare CIC was £280,595 (2023: £Nil) shown in creditors.
During the year, there was a total of £116,443 (2023: £Nil) paid to two directors and the company secretary for payment of services provided to the Company. As at the year end, there was £2,625 (2023: £Nil) owed and is included within creditors.

 
Page 12